期刊文献+

温肾健脾方治疗腹泻型肠易激综合征疗效观察 被引量:9

Clinical effect of prescription with worming kidney and tonifying spleen in treating diarrhea-predominant irritable bowel syndrome
下载PDF
导出
摘要 [目的]观察温肾健脾方治疗腹泻型肠易激综合征的疗效。[方法]将119例患者随机分为治疗组和对照组。治疗组采用温肾健脾方加减治疗;对照组口服枯草杆菌肠球菌二联活菌肠溶胶囊,均以4周为1个疗程,治疗2个疗程后统计疗效。[结果]治疗组总有效率为88.3%,对照组总有效率为72.9%,临床疗效优于对照组(P<0.05)。[结论]温肾健脾方是治疗腹泻型肠易激综合征行之有效的方法。 [Objective] To assess the effects of kidney-warming spleen-invigorating formula (KWSFF) in treating diarrhea-predominant irritable bowel syndrome (IBS). [Methods] One hundred and nineteen patients with dialThea-predominant IBS were randomly divided in two groups: the control group and the treatment group. The treatment group received modified KWSFF based on symptoms, while the control group was given Bacillus subtilis enterococcus duplex viable enteric capsules orally. Four weeks was a course. Both of the two groups were treated for two courses and then the therapeutic effect was statistically analyzed. [Results] The total efficiency rate of treatment group was 88.3%, and that in the control group was 72.9%. Clinical efficacy of the treatment group was better than the control group(P〈0.05). [Conclusion] KWSFF is a effective method in treating diarrhea-predominant IBS.
作者 高颖
出处 《天津中医药》 CAS 2013年第5期272-273,共2页 Tianjin Journal of Traditional Chinese Medicine
关键词 肠易激综合征 腹泻型 温肾健脾方 疗效观察 imtable bowel syndrome diarrhea-predominant warming kidney and fortifying spleen prescription observation of therapeu-tic effect
  • 相关文献

参考文献3

二级参考文献13

  • 1Drossman DA.Psychosocial and psychophysiologic mechanisms in GI Ⅲ ness.In:Kirsner JB,ed.The growth of gastroenterologic knowledge in the 20th century.Philadelphia:Lea & Febiger; 1993.41~432.
  • 2Whitehead WE,Palsson O,Jones KR.Systematic review of the comorbidity of irritable bowel syndrome with other disorders:what are the causes and implications? Gastroenterology,2002,122:1140~1156.
  • 3Drossman DA,Camilleri M,Mayer EA,Whitehead WE.AGA technical review on irritable bowel syndrome.Gastroenterology,2002,123:2108~2131.
  • 4Lea R,Whorwell PJ.New insights into the psychosocial aspects of irritable bowel syndrome.Curr Gastroenterol Rep,2003,5:343~350.
  • 5Drossman DA.The functional gastrointestinal disorders and the Rome Ⅲ process.Gastroenterology,2006,130:1377~1390.
  • 6Longstreth GF,Thompson WG,Chey WD,Houghton LA,Mearin F,Spiller RC.Functional bowel disorder.Gastroenterology,2006,130:1480~1491.
  • 7O'Donnell LJ,Virjee J,Heaton KW.Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate.BMJ,1990,300:439~440.
  • 8Longstreth GF,Drossman DA.Severe irritable bowel and functional abdominal pain syndromes:managing the patient and health care costs.Clin Gastroenterol Hepatol,2005,3:397~400.
  • 9Chey WD,Chey WY,Heath AT,Dukes GE,Carter EG,Northcutt A,Ameen VZ.Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome.Am J Gastroenterol,2004,99:2195~2203.
  • 10Muller-Lissner S,Holtmann G,Rueegg P,Weidinger G,Loffier H.Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation.Aliment Pharmacol Ther,2005,21:11~20.

共引文献279

同被引文献108

引证文献9

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部